— Know what they know.
Not Investment Advice

PGNY NASDAQ

Progyny, Inc.
1W: -0.8% 1M: -4.0% 3M: -18.4% YTD: -2.0% 1Y: +18.9% 3Y: -27.1% 5Y: -60.2%
$25.23
+0.38 (+1.53%)
 
Weekly Expected Move ±4.1%
$23 $24 $25 $26 $27
NASDAQ · Healthcare · Medical - Healthcare Plans · Tech Score Sell · Power 39 · $2.0B mcap · 72M float · 1.73% daily turnover · Short 46% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.0B
52W Range16.1-33.07
Volume939,641
Avg Volume1,242,856
Beta0.99
Dividend—
Analyst Ratings
14 Buy 6 Hold 0 Sell
Consensus Buy
Company Info
CEOPete Anevski
Employees846
SectorHealthcare
IndustryMedical - Healthcare Plans
IPO Date2019-10-25
1359 Broadway
New York City, NY 10018
US
212 888 3124
About Progyny, Inc.

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

Recent Insider Trades

NameTypeSharesPriceDate
Swartz Allison S-Sale 3,903 $26.10 2026-09-23
Clapp Geoffrey F-InKind 819 $27.38 2026-09-17
GORDON KEVIN K S-Sale 11,500 $27.12 2026-09-10
GORDON KEVIN K F-InKind 10,500 $27.24 2026-09-10
GORDON KEVIN K S-Sale 11,500 $27.94 2026-09-10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms